Septicemia Clinical Trial
Official title:
The Impact of a Rapid Molecular Identification Test on Positive Blood Cultures From Critically Ill With Bacteremia: a Pre-post Intervention Study
Molecular testing is a largely validated approach allowing rapid identification of positive blood cultures. However, due to its high cost and its limited information on susceptibility, it is considered as an add-on technique reserved for specific patient populations. In our study, we specifically evaluated molecular testing in a critical care setting and measured its impact on the therapeutic management of critically ill with positive blood cultures. Through the analysis of 110 positive blood culture episodes included in both pre- and post intervention period, we measured a drastic 14h-reduction of the time to administration of the optimal antimicrobial treatment with the use of the molecular approach.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT04764058 -
Efficacy and Safety of Colistin Based Antibiotic Therapy
|
Phase 1/Phase 2 | |
Completed |
NCT03088865 -
Evaluation of an Internal Hospital Practice: The Effect of Altered Test Tubes Sampling Order on Blood Culture Contamination Rates
|
N/A | |
Completed |
NCT00046072 -
A Safety and Efficacy Study of Intravenous E5564 in Patients With Severe Sepsis
|
Phase 2 | |
Completed |
NCT01520597 -
National Study on Listeriosis and Listeria
|
||
Recruiting |
NCT03929159 -
Correlating MicroRNA Changes With Sepsis Outcomes
|
||
Completed |
NCT00901940 -
Understanding the Immune Response to Meningitis Vaccines
|
Phase 3 | |
Not yet recruiting |
NCT03583762 -
Time to Appropriate Antibiotic Between Using Microarray Assay and Mass Spectrometry Technique
|
N/A | |
Completed |
NCT02988414 -
Diagnosis of Bacteremia/Septicemia and Culture Negative Endocarditis by the Karius Sequencing-Based Infectious Disease Diagnostic Assay
|
||
Completed |
NCT02102087 -
Study to Evaluate the Effectiveness of the Initial Specimen Diversion Device
|
N/A | |
Recruiting |
NCT05045963 -
Impact of Aminoglycosides in Hypotensive Septic Oncology Patients
|
||
Terminated |
NCT02093494 -
Study to Evaluate the Effectiveness of the Initial Specimen Diversion Device When Collected Through Peripheral Intravenous Catheters
|
N/A | |
Active, not recruiting |
NCT02069028 -
Effectiveness of Different Interventions for Implementing Surviving Sepsis Campaign (SSC) Guidelines on Compliance and Mortality: Systematic Review and Meta-analysis
|
N/A | |
Recruiting |
NCT00258869 -
Observational Study of Sepsis and Pneumonia to Develop Diagnostic Tests
|
N/A | |
Completed |
NCT05358912 -
Efficacy of Targeted Abdominal Perfusion Pressure in Septic Shock
|
Phase 4 | |
Recruiting |
NCT05893420 -
A Rapid Diagnostic of Risk in Hospitalized Patients Using Machine Learning
|
N/A | |
Recruiting |
NCT05040503 -
Monitoring Mitophagy In Myeloid Cells Upon Intensive Care
|
N/A | |
Completed |
NCT00146432 -
Immunoadsorption of LPS, C5a and IL-6 in Severe Sepsis and Septic Shock (ISASS-1)
|
Phase 2/Phase 3 | |
No longer available |
NCT04636554 -
Personalized Phage Treatment in Covid-19 Patients With Bacterial Co-Infections Microbials for Pneumonia or Bacteremia/Septicemia
|